Home » UCB Shares Slump After Drug Setback, Broker Notes
UCB Shares Slump After Drug Setback, Broker Notes
Shares in UCB tumbled more than 15 percent after the Belgian pharmaceutical group announced that U.S. regulators had failed to approve a pain relief drug and following broker downgrades.
guardian.co.uk
Upcoming Events
-
07May
-
14May
-
30May